Neuroimmunology and Neuroinflammation

LATEST MOST VIEWED: LAST ONE YEAR MOST VIEWED: LAST TWO YEARS MOST DOWNLOADED

Technical Note| Open Access
Classification of brain tumor using devernay sub-pixel edge detection and k-nearest neighbours methodology
Ayush Arora , Ritesh Kumar , Shubham Tiwari , Mysore Shwetha , Selvam Venkatesan , Ramesh Babu
Any disease can be treated only once it is imaged, detected and classified. This paper proposes a set of algorithms for classification of a brain tumor with better accuracy and efficiency. The proposal uses a JPEG format of the DICOM image fed into three stages namely pre-processing, segmentation... Read more

Any disease can be treated only once it is imaged, detected and classified. This paper proposes a set of algorithms for classification of a brain tumor with better accuracy and efficiency. The proposal uses a JPEG format of the DICOM image fed into three stages namely pre-processing, segmentation using sub-pixel edge detection method and using the nearest neighbor methodology for the detection and differentiation of benign and malignant tumors. Back
This article belongs to the Special Issue Immunotherapeutic Approaches for Treatment of Brain Tumors Neuroimmunol Neuroinflammation 2018;5:26. | doi:10.20517/2347-8659.2018.11
Published on: 19 Jun 2018 | Viewed：106 | Downloaded：5
+HTML| PDF
Review| Open Access
A concise review of immunotherapy for glioblastoma
Omer Sager , Ferrat Dincoglan , Selcuk Demiral , Bora Uysal , Hakan Gamsiz , Bahar Dirican , Murat Beyzadeoglu
Glioblastoma (GB) is the most common and aggressive form of primary brain tumors in adults with a universally poor prognosis despite multimodal management including surgery, chemotherapy and radiation therapy. Among the novel therapeutic strategies, immunotherapy deserves particular attention... Read more

Glioblastoma (GB) is the most common and aggressive form of primary brain tumors in adults with a universally poor prognosis despite multimodal management including surgery, chemotherapy and radiation therapy. Among the novel therapeutic strategies, immunotherapy deserves particular attention with its potential to evoke biologic response and harness the host immune system. Considerable success achieved for other tumors has elicited great enthusiasm and prompted research on immunotherapy for GB. While the central nervous system has traditionally been thought of as an immune-privileged site, our understanding is being refined with emerging evidence. Several studies have been conducted and more are under way to establish the role of immunotherapy in management of GB. Immunotherapy of GB has yet resulted in mixed success with conflicting research findings, emphasizing the need for extensive study before its integration into routine clinical practice. Although there is a lot of room for improvement, immunotherapy for GB may be feasible and serve as a viable management strategy broadening and strengthening the therapeutic armamentarium to combat this deadly disease. Herein, we present a concise review of immunotherapy for GB. Back
This article belongs to the Special Issue Immunotherapeutic Approaches for Treatment of Brain Tumors Neuroimmunol Neuroinflammation 2018;5:25. | doi:10.20517/2347-8659.2018.12
Published on: 15 Jun 2018 | Viewed：67 | Downloaded：8
+HTML| PDF
Commentary| Open Access
Commentary on “Depression severity and its predictors among multiple sclerosis patients in Saudi Arabia: a cross-sectional study”
Thomas Müller Neuroimmunol Neuroinflammation 2018;5:23. | doi:10.20517/2347-8659.2018.27
Published on: 7 Jun 2018 | Viewed：125 | Downloaded：7
+HTML| PDF
Original Article| Open Access
Shifting paradigm in brain abscess management at tertiary care centre in Nepal
Prakash Kafle , Mohan Raj Sharma , Sushil Krishna Shilpakar , Gopal Sedain , Amit Pradhanang , Ram Kumar Shrestha , Binod Raj Bhandari , Christine Groves
Aim: Brain abscess is a challenging clinical entity with substantial high case fatality rates despite significant advances in imaging techniques, laboratory modalities, surgical interventions, and antimicrobial treatment.Otogenic and cardiogenic sources are among the most common. Classic clinical... Read more

Aim: Brain abscess is a challenging clinical entity with substantial high case fatality rates despite significant advances in imaging techniques, laboratory modalities, surgical interventions, and antimicrobial treatment.Otogenic and cardiogenic sources are among the most common. Classic clinical presentation is seen in very few cases only. Burr hole with aspiration works well with good clinical outcomes. Control of primary source in cases of ear infection in the single setting results in good outcomes, reduces for additional surgery, and decreases the duration of hospital stay. Methods: This is prospective observational study conducted at Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal over the period of two and a half years (from September 2014 to March 2017).We analyzed the demographic profile, management strategies and outcome of these cases diagnosed with brain abscess using Microsoft Excel 2007. Results: A total of 51 cases were undertaken for surgical management. There were 35 males and 16 females with the male to female ratio of 2.18:1. The mean age of the study population was 16.76 years with age range from 4 months to 60 years. Otogenic source was the most common. Temporal lobe was the most common abscess location. Headache was the most common clinical presentation and was seen in 86.27% of the study population. All cases were initially managed with burrhole and aspiration of the abscess. Only 3.92% (n = 2) of cases subsequently required surgical excision of the abscess wall. Only 11.76 % (n = 6) of the cases required multiple aspiration. Only 19.61% (n = 10) showed positive culture. Pseudomonas aeruginosa and E. coli were the most common organisms grown. Mortality rate among the study group was 3.92%. Conclusion: With the advent of modern technology in neuroimaging, mortality due to brain abscess has significantly decreased. Joint involvement of the otorhinolaryngology team and efforts in addressing the primary source have further helped in improving outcomes in cases of otogenic brain abscess. Hence, source control is of paramount importance in managing the brain abscess. Back
Neuroimmunol Neuroinflammation 2018;5:24. | doi:10.20517/2347-8659.2018.10
Published on: 7 Jun 2018 | Viewed：91 | Downloaded：11
+HTML| PDF
Commentary| Open Access
Commentary on interactions between neurotropic pathogens, neuroinflammatory pathways, and autophagic neural cell death
Michaela Cellina , Marcello Orsi Neuroimmunol Neuroinflammation 2018;5:22. | doi:10.20517/2347-8659.2018.15
Published on: 5 Jun 2018 | Viewed：90 | Downloaded：7
+HTML| PDF
Original Article| Open Access
Surgical management of clinoidal meningiomas: 10 cases analysis
Shamsul Alam , Bipin Kumar Chaurasia , Narendra Shalike , Abu Naim Wakil Uddin , Dhiman Chowdhury , Akhlaque Hossain Khan , Ayub Ansari , Kanak Kanti Barua , Mashiur Rahman Majumder
Aim: The purpose of this article is to advocate standard skull base technique for removing the clinoidal meningioma and to delineate the technique’s advantages that aid in achieving an improved extent of tumor resection and enhancing the patients’ overall outcome, specially their visual outcome.... Read more

Aim: The purpose of this article is to advocate standard skull base technique for removing the clinoidal meningioma and to delineate the technique’s advantages that aid in achieving an improved extent of tumor resection and enhancing the patients’ overall outcome, specially their visual outcome. Methods: A retrospective analysis was performed on 10 consecutive patients with clinoidal meningiomas who underwent surgical resection at the Bangabandhu Sheikh Mujib Medical University and other private clinics between May 2013 and July 2016. A standard pterional craniotomy technique consisting of extradural anterior clinoidectomy, coupled with optic canal unroofing and optic nerve sheath opening was used in all patients. All patients had thorough preoperative and postoperative ophthalmological evaluations. The follow-up period ranged from 6 to 42 months. Results: Total resection was achieved in 5 (50.0%) of the 10 patients in this series. The majority of the patients with preoperative visual impairment experienced significant visual improvement 7 of 10 patients; 70.0%). Conclusion: In the majority of patients with clinoidal meningiomas, total resection may be achieved with minimal complications. For large tumors encasing the optic nerve and internal carotid artery, or for those tumors causing preoperative visual impairment, use of the cranial base technique delineated in this study may lead to significant improvement in the patients’ visual and overall outcomes. Back
This article belongs to the Special Issue Brain Tumor Neuroimmunol Neuroinflammation 2018;5:21. | doi:10.20517/2347-8659.2017.64
Published on: 24 May 2018 | Viewed：411 | Downloaded：18
+HTML| PDF
Case Report| Open Access
Hypoparathyroidism presenting with late onset seizures - a report of two cases from rural India
Archana Verma , Alok Kumar
Hypoparathyroidism leading to hypocalcaemia is an important treatable cause of recurrent seizures. Neurological manifestations due to hypoparathyroidism include: seizures, paresthesia, depression, psychosis, extra pyramidal symptoms, and features of raised intracranial pressure. Seizures may be... Read more

Hypoparathyroidism leading to hypocalcaemia is an important treatable cause of recurrent seizures. Neurological manifestations due to hypoparathyroidism include: seizures, paresthesia, depression, psychosis, extra pyramidal symptoms, and features of raised intracranial pressure. Seizures may be the presenting symptoms preceding other signs of hypocalcaemia. Primary hypoparathyroidism presenting for the first time as seizures in the elderly is quite rare. Here we report two cases of hypoparathyroidism presenting with seizures in the elderly as the sole manifestation of hypocalcaemia. The goal of this report is to seek attention to such an uncommon reversible treatable cause of seizures and to consider hypoparathyroidism in the work up of these patients. Back
Neuroimmunol Neuroinflammation 2018;5:20. | doi:10.20517/2347-8659.2017.65
Published on: 23 May 2018 | Viewed：152 | Downloaded：8
+HTML| PDF
Editorial| Open Access
Bone mineral density in patients with multiple sclerosis
Chrissa Sioka , Andreas Fotopoulos Neuroimmunol Neuroinflammation 2018;5:18. | doi:10.20517/2347-8659.2018.06
Published on: 22 May 2018 | Viewed：87 | Downloaded：12
+HTML| PDF
Case Report| Open Access
Demyelinating central nervous system lesions, following the use of tumor necrosis factor alpha antagonist
Emmanuel Bogdos , Sofia Markoula , Anastasia Zikou , Paraskevi Voulgari , Aleksandros Drosos , Spyridon Konitsiotis
Tumor necrosis factor alpha (TNFα) antagonists have been a valuable tool in treating patients with rheumatoid arthritis (RA), but reports and case series of neurological adverse events due to TNFα antagonists have been reported. Furthermore, central nervous system (CNS) lymphoma always remains a... Read more

Tumor necrosis factor alpha (TNFα) antagonists have been a valuable tool in treating patients with rheumatoid arthritis (RA), but reports and case series of neurological adverse events due to TNFα antagonists have been reported. Furthermore, central nervous system (CNS) lymphoma always remains a remote, yet a worrisome complication in RA patients, especially in those under treatment with methotrexate (MTX). We present a female patient with RA with tumor-like active demyelinating lesions attributed to TNFα antagonist, confirmed by an FNA biopsy, otherwise clinically and radiologically challenging to distinguish from CNS lymphoma. A 72-year-old female patient with RA under TNFα antagonist and MTX treatment was presented with neurological symptoms and signs. The brain MRI revealed four tumor-like contrast-enhancing lesions bilaterally, the demyelinating nature of which was delineated by the FNA biopsy. A full clinical and radiological recovery was achieved after the TNFα antagonist was permanently withdrawn. Patients with RA under anti-TNF agents and MTX are predisposed to complications such as CNS lymphoma and CNS demyelination. This case uniquely highlights the physicians’ vigilance in pursuing these complications and the usage of the FNA when tumor-like appearances on the brain MRI convolute the final diagnosis. Back
Neuroimmunol Neuroinflammation 2018;5:19. | doi:10.20517/2347-8659.2018.07
Published on: 22 May 2018 | Viewed：122 | Downloaded：6
+HTML| PDF
Commentary| Open Access
The emerging TDP-43 proteinopathy
George P. Paraskevas , Mara Bourbouli , Ioannis Zaganas , Elisabeth Kapaki Neuroimmunol Neuroinflammation 2018;5:17. | doi:10.20517/2347-8659.2018.18
Published on: 10 May 2018 | Viewed：518 | Downloaded：32
+HTML| PDF

+More| View all articles

EDITOR'S PICKS

Quick Links

Publications

Partners